Clinical Trial Update: The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for INVIGORATE 2 evaluating efficacy and safety in seasonal allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• INVIGORATE 2

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED